Endo Health Solutions Inc. Watch

from 8-K 139 pages Credit Agreement Dated as of June 17, 2011 Among Endo Pharmaceuticals Holdings Inc. the Lenders Party Hereto Morgan Stanley Senior Funding, Inc. as Administrative Agent and Bank of America, N.A. as Syndication Agent and Citibank, N.A., Deutsche Bank Securities Inc. and Dnb Nor Bank Asa, New York Branch as Co-Documentation Agents Morgan Stanley Senior Funding, Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated as Joint Bookrunners and Joint Lead Arrangers

from 10-K 176 pages Credit Agreement Dated as of November 30, 2010 Among Endo Pharmaceuticals Holdings Inc. the Lenders Party Hereto Jpmorgan Chase Bank, N.A. as Administrative Agent Royal Bank of Canada as Syndication Agent and Barclays Bank PLC as Documentation Agent J.P. Morgan Securities LLC and Rbc Capital Markets1 as Joint Bookrunners and Joint Lead Arrangers

from 10-Q 16 pages Amendment No. 2 Dated as of October 25, 2010 to Credit Agreement Dated as of October 16, 2009

from 8-K 99 pages Credit Agreement Dated as of October 16, 2009 Among Endo Pharmaceuticals Holdings Inc. the Lenders Party Hereto Jpmorgan Chase Bank, N.A. as Administrative Agent and Barclays Capital as Syndication Agent J.P. Morgan Securities Inc. and Barclays Capital as Joint Bookrunners and Joint Lead Arrangers

from 10-K 5 pages Ubs Is Offering You “Auction Rate Securities Rights” (Rights) to Sell Eligible Ars at Par Value to Ubs at Any Time During a Two-Year Time Period. These Rights Are Nontransferable Securities Registered With the U.S. Securities and Exchange Commission (SEC). This Is a Limited Time Offer That Will Expire on November 14, 2008, Accepting This Offer May Impact Your Legal Rights. Not Accepting This Offer May Have Repercussions on Outstanding Loans Secured by Eligible Ars. as a Result, It Is Important That You Review the Prospectus Carefully. the Key Features and Terms of the Offer Are Summarized Below. for Complete Details, Please See the Enclosed Prospectus. • Ubs Is Offering You Nontransferable Rights to Sell Eligible Ars, Held in the Ubs Account Identified Above, at Par Value to Ubs at Any Time During the Period of June 30, 2010, Through July 2, 2012. • You May Instruct Your Ubs Financial Advisor to Exercise These Rights at Any Time During This Time Period; • if You Do Not Exercise Your Rights, the Eligible Ars Will Continue to Accrue Interest or Dividends as Determined by the Auction Process; • if You Do Not Exercise Your Rights Before July 2, 2012, They Will Expire and Ubs Will Have No Further Obligation to Buy Your Eligible Ars. • Clients Who Accept This Offer Give Ubs the Discretion to Purchase or Sell Their Eligible Ars at Any Time After Accepting the Firm’s Offer and Without Other Prior Notice

from 10-K 8 pages Termination Agreement

from 10-Q ~1 page Amendment No. 2 to the Amended and Restated Credit Agreement

from 8-K 66 pages This Agreement (This “Agreement”) Is Made the 14th Day of July, 2004. Between

from 10-Q 9 pages Amended and Restated Credit Agreement

from 10-K >50 pages Amended and Restated Credit Agreement

from S-4 >50 pages Credit Agreement